Adaptimmune Therapeutics
ADAP
#8469
Rank
ยฃ0.12 B
Marketcap
ยฃ0.47
Share price
1.35%
Change (1 day)
32.88%
Change (1 year)

EPS for Adaptimmune Therapeutics (ADAP)

EPS in 2023 (TTM): -ยฃ0.45

According to Adaptimmune Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ0.42. In 2022 the company made an earnings per share (EPS) of -ยฃ0.80 a decrease over its 2021 EPS that were of -ยฃ0.80.

EPS history for Adaptimmune Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ0.45-43.49%
2022-ยฃ0.80-0%
2021-ยฃ0.806.25%
2020-ยฃ0.76-27.27%
2019-ยฃ1.0429.41%
2018-ยฃ0.8020.09%
2017-ยฃ0.67-16.73%
2016-ยฃ0.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-ยฃ5.66 1,247.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.74 76.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ3.10 638.20%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
ยฃ0.22-153.08%๐Ÿ‡บ๐Ÿ‡ธ USA